Table 1.
Patient characteristics
| N | Age (years) | Gender (female) | CD4 (cells/μL) | Plasma HIV RNA | |
|---|---|---|---|---|---|
| Group | Median (IQR) | Number (%) | Median (IQR) | Log10 copies/mL | |
| HIV negative | 13 | 39 (29–47) | 3 (23) | 702* | N.A |
| HIV neuroasymptomatic | |||||
| CD4 > 350 | 30 | 41 (32–45) | 10 (33) | 462 (397–618) | 4.17 (3.72–4.57) |
| CD4 200–349 | 25 | 39 (32–48) | 9 (36) | 240 (220–290 | 4.74 (4.32–5.04) |
| CD4 50–199 | 25 | 42 (34–51) | 13 (52) | 110 (90–139) | 5.09 (4.66–5.42) |
| CD4 < 50 | 25 | 44 (36–48) | 9 (36) | 20 (10–30) | 5.49 (5.00–5.90) |
| HIV-associated dementia | 11 | 43 (40–57) | 0 (0) | 60 (39–137) | 5.69 (5.46–5.82) |
| Neuroasymptomatic, ART | 33 | 44 (36–54) | 13 (39) | 580 (450–830) | < 1.30 (< 1.30–< 1.30) |
N number, IQR interquartile range, NA not analyzed, ART antiretroviral therapy, CSF cerebrospinal fluid
*CD4 only available for four controls, IQR not presented